Mounjaro 7.5mg: what happens at this stage of treatment

Step 1: how you arrive at the 7.5mg pen

Mounjaro's licensed UK schedule starts at 2.5mg. That first pen exists to let your system adjust gradually, not to drive weight loss from week one. After four weeks, a prescriber typically moves treatment to 5mg. Four weeks after that, if 5mg has been tolerated reasonably well, 7.5mg becomes the next logical step.

The key word is 'typically'. Some people need longer at 5mg because of persistent nausea or other gut symptoms. Others move through more smoothly. Titration is a clinical conversation, not a countdown. If you're thinking about what the move from 5mg to 7.5mg actually involves, that page covers the practical transition in more detail.

By the time you reach the 7.5mg Mounjaro pen, the titration pattern is familiar: one injection per week, same day each week, rotating between the abdomen, thigh and upper arm. Storage stays the same too — refrigerated between 2°C and 8°C, and the exact guidance on taking it out of the fridge before use is in the Patient Information Leaflet that arrives with the pen. The Mounjaro overview page has a fuller picture of the pen itself and how it works.

Step 2: what 7.5mg does differently to the doses before it

Tirzepatide works by activating two gut-hormone receptors simultaneously — GIP and GLP-1. Both slow gastric emptying and help regulate appetite signals between the gut and brain. At higher doses, this dual action tends to produce stronger and more consistent appetite suppression for most people.

The clinical trial evidence bears this out. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants on the highest doses of tirzepatide achieved average body-weight reductions of around 20–21% over 72 weeks. The 7.5mg dose sits in the mid-range of the schedule, below the 10, 12.5 and 15mg levels where the largest trial results were recorded, but it is not a minor step. For many people, it represents the first point in treatment where weight-loss momentum feels noticeably different to what came before.

If you want to see how measured outcomes tend to differ across dose levels, this page looks specifically at weight-loss results reported at 7.5mg. It's worth reading alongside the trial data rather than instead of it, individual results vary, and a prescriber's assessment of your response matters more than any average figure.

Step 3: side effects to be aware of at this strength

The side-effect profile at 7.5mg is broadly the same as at earlier doses, gastrointestinal symptoms lead the list. Nausea, loose stools, constipation, reflux and burping are the most commonly reported effects. They tend to be most noticeable in the first week or two after a dose increase, then settle as the body adapts.

Moving up to 7.5mg can briefly reintroduce some of that early-treatment nausea, even if 5mg felt fine by the end. Eating smaller portions, staying hydrated and avoiding rich or fatty meals around injection day helps most people manage this. The NHS tirzepatide information page lists the full side-effect profile and explains which symptoms should prompt you to call a doctor rather than wait.

One side effect worth knowing about specifically: severe, persistent stomach pain that spreads to the back (with or without vomiting) needs urgent medical attention. This can be a sign of pancreatitis, which the MHRA has identified as a known, if infrequent, risk with GLP-1 medicines. It is not a reason to avoid treatment, but it is a reason to know the warning sign and act on it quickly.

A question our prescribers hear most weeks at this stage: 'do I push through the nausea or stay at the same dose a little longer?' The honest answer is that staying at 5mg for another four weeks before stepping up is entirely reasonable if symptoms are affecting daily life. The goal is sustainable treatment, not the fastest possible titration.

Step 4: what clinical review looks like before 7.5mg is prescribed

At nume, no dose change happens without a prescriber reading your update first. You record your current weight (verified on a short video call) and report how 5mg has gone: tolerability, any side effects, how appetite has changed. A named prescriber, not an automated system, reviews that information the same day. If 7.5mg is clinically appropriate, the pen is dispatched once approved, arriving with DPD the next working day in plain packaging. Order before midday on a weekday and the same-day dispatch timeline typically holds, a useful detail if your current pen is running low and you're watching the calendar.

Thinking about what the dose looks like in practice? The 7.5mg pen clicks guide explains the injection mechanism, and this page covers the 7.5mg volume in ml for anyone who wants to understand the numbers. For a direct comparison of this strength against the previous one, the 5mg versus 7.5mg page sets them side by side.

If you're weighing up the cost of ongoing private treatment, the Mounjaro cost page explains how private pricing works and what a single transparent price from a regulated pharmacy actually covers. Ready to talk through whether this stage of treatment is right for you? Speak to our prescribers through a free consultation.